Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.69M Sell
4,052
-1,774
-30% -$678K 1.41% 23
2026
Q1
$1.87M Buy
5,826
+632
+12% +$171K 2.12% 16
2025
Q4
$1.13M Buy
+5,194
New +$1.09M 1.33% 23

Other funds holding MTZ

Blue Line Capital's MTZ Position: Q2 2026 in Review

Blue Line Capital reduced its MasTec (MTZ) stake by 30% in Q2 2026, selling an estimated $678K and leaving 4,052 shares worth $1.69M. The position accounts for 1.41% of the portfolio, ranked #23.

Blue Line Capital first reported a position in MTZ in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.87M in Q1 2026. 909 funds tracked by Wall St. Rank hold MTZ as of Q2 2026.

  • Blue Line Capital held 4,052 shares of MasTec worth $1.69M as of Q2 2026.
  • Blue Line Capital sold 1,774 MasTec shares in Q2 2026, an estimated $678K.
  • MasTec made up 1.41% of Blue Line Capital's portfolio in Q2 2026, its #23 holding.
  • Blue Line Capital first reported a position in MasTec in Q4 2025 and has held it in 3 quarters since.
  • Blue Line Capital's MasTec position peaked at $1.87M in Q1 2026.
  • 909 funds tracked by Wall St. Rank held MasTec as of Q2 2026.

Based on Blue Line Capital's 13F filing for Q2 2026, filed 30 Jul 2026.